At a glance
- Originator Eli Lilly and Company
- Class Pyrrolidines; Small molecules; Thiophenes
- Mechanism of Action Antioxidants; Apoptosis stimulants; Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atherosclerosis; Cancer